Predictive value of immunological and imaging biomarkers on achieving remission at 6 months in rheumatoid arthritis patients treated by intravenous bDMARDs

Category Primary study
JournalAnnals of the Rheumatic Diseases
Year 2020
This article has no abstract
Epistemonikos ID: 25a3863ffcd14e63d1bda0382e354462d07146dc
First added on: Mar 23, 2022